Sensei Biotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Sensei Biotherapeutics, Inc. (SNSE) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents9.9913.0117.807.1616.60
Short-Term Investments31.3452.7589.32140.460.00
Cash & Short-Term Investments41.3465.76107.12147.6216.60
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.590.330.340.551.38
Total Current Assets41.9367.25108.59148.5420.08
Non-Current Assets
Property, Plant & Equipment (Net)3.387.049.724.641.27
Other Non-Current Assets0.050.090.060.040.09
Total Non-Current Assets3.437.129.794.680.00
Total Assets45.3674.37118.38153.2321.43
Current Liabilities
Accounts Payable1.251.694.472.463.88
Short-Term Debt2.320.000.000.000.00
Accrued Liabilities2.732.412.461.750.92
Other Current Liabilities1.881.512.461.750.00
Total Current Liabilities5.455.649.074.894.83
Non-Current Liabilities
Long-Term Debt1.533.775.901.670.57
Other Non-Current Liabilities0.000.070.000.150.05
Total Non-Current Liabilities1.533.845.901.820.00
Total Liabilities6.989.4814.976.715.54
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-262.05-231.90-197.79-149.21-112.41
Accumulated Other Comprehensive Income-0.01-0.21-1.00-0.330.00
Additional Paid-in Capital300.45297.00302.20296.050.00
Shares Outstanding1.261.251.541.530.00
Total Stockholders' Equity38.3964.90103.41146.5115.89
Total Liabilities & Equity45.3674.37118.38153.230.00